Literature DB >> 1687013

Human liver arylamine N-sulfotransferase activity. Thermostable phenol sulfotransferase catalyzes the N-sulfation of 2-naphthylamine.

J S Hernández1, S P Powers, R M Weinshilboum.   

Abstract

Our experiments were performed to determine whether human liver, like that of other mammals, could catalyze the N-sulfation of an arylamine, 2-naphthylamine (2-NA) and, if so, whether this reaction might be catalyzed by one or both of the two known forms of human phenol sulfotransferase (PST). One form of PST is thermostable (TS) and catalyzes the sulfation of "simple" phenols such as p-nitrophenol, while the other form is thermolabile (TL) and catalyzes the sulfate conjugation of phenolic monoamines such as dopamine. When 2-NA that was not contaminated with 2-naphthol was used as substrate, human hepatic cytosol could catalyze the N-sulfation of 2-NA with an apparent Km of 322 microM. However, substrate kinetics of the sulfate donor for the reaction, 3'-phosphoadenosine-5'-phosphosulfate, were biphasic, with estimated apparent Km values of 0.13 and 2.2 microM for high and low affinity activities, respectively. Human liver arylamine N-sulfotransferase (AANST) activity was similar to that of TS but not TL PST with regard to thermal stability, inhibition by 2,6-dichloro-4-nitrophenol (DCNP), and regulation among individuals. For example, average temperatures that produced 50% inactivation of TL PST, TS PST, and AANST activities, measured with both 0.05 and 1.0 mM 2-NA as substrate, were 35.0, 40.5, 40.3 and 40.5 degrees C, respectively. IC50 values for the inhibition by DCNP of TL PST, TS PST, and AANST, measured with 0.05 and 1.0 mM 2-NA as substrate, were 110, 1.8, 1.3, and 4.0 microM, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687013

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  4 in total

1.  Inhibition of phenolsulphotransferase by salicylic acid: a possible mechanism by which aspirin may reduce carcinogenesis.

Authors:  R M Harris; R J Hawker; M J Langman; S Singh; R H Waring
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

Review 2.  Pharmacogenetics of soluble sulfotransferases (SULTs).

Authors:  Hansruedi Glatt; Walter Meinl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-05       Impact factor: 3.000

3.  The role of aspirin in carcinogenesis.

Authors:  G J Caine; S T Kehoe; G Y H Lip
Journal:  Br J Cancer       Date:  2002-11-18       Impact factor: 7.640

4.  Species differences in metabolism of heterocyclic aromatic amines, human exposure, and biomonitoring.

Authors:  R J Turesky; G A Gross; W G Stillwell; P L Skipper; S R Tannenbaum
Journal:  Environ Health Perspect       Date:  1994-10       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.